As cybersecurity breaches grow more complex and frequent, regulators are increasingly focused on organizational compliance. Organizations such as Crowdstrike report that in 2025, cyberattacks are increasing in speed, volume, and sophistication—and cybercrime has evolved as a “highly efficient business.” The escalating threat landscape demands robust security frameworks that can withstand evolving risks.
Enter the amendments announced in November 2023 to the New York’s Department of Financial Services (NYDFS) Cybersecurity Regulation, 23 NYCRR Part 500 (“Amended Regulation”), that became effective on November 1. This post explores the breadth of these Amended Regulations, and the steps that covered entities need to take now.
Based on their extensive experience advising health care industry clients, Epstein Becker Green attorneys and strategic advisors from EBG Advisors are predicting the “hot” health care sectors for investment, growth, and consolidation in 2020. These predictions for 2020 are largely based on the increasing confluence of the following three key “drivers” of health industry transformation that is substantially underway:
- The ongoing national imperative of reducing the cost of health care, via disease prevention and detection, and cost-effective, quality treatment, including more efficient care in ambulatory and retail settings;
- Extraordinary advances in technologies which enhance disease prevention, detection and cost-effective treatment (e.g., artificial intelligence (AI)-driven diagnosis and treatment, virtual care, electronic medical record (EMR) systems, medical devices, gene therapy, and precision medicine); and
- The aging baby-boomer population, with tens of millions of Americans entering into their 70s, 80s, and above.
Recent Updates
- When AI Becomes Part of Medicine: Why CMS’s AI Questions Matter Now
- Watch: Gender-Affirming Care: What Health Care Providers Need to Know About Federal Enforcement – Thought Leaders in Health Law
- Executive Order 14321 at One Year: Civil Commitment Policy Shifts and Provider Impact
- Watch: FDA’s 2026 Enforcement Priorities: What In-House Counsel Must Know – Thought Leaders in Health Law
- The Future of 340B: New Bills Offer Competing Solutions to Modernize the 340B Drug Discount Program